Gritstone Oncology Announces Updated Presentation Time at

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
28
Gritstone Oncology Announces Updated Presentation Time at the 37th Annual J.P. Morgan Healthcare Conference

EMERYVILLE, Calif., Jan. 06, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced that Andrew Allen, M.D., Ph.D., co-founder, president and chief executive officer, will present a company overview on Tuesday, Jan. 8, 2019 at 10:00 a.m. PST during the 37th Annual J.P. Morgan Healthcare Conference in San Francisco. The company will hold a question and answer session immediately following the presentation.

A live audio webcast will be available within the Investors & Media section of the Gritstone Oncology website at https://ir.gritstoneoncology.com/investors/events. An archived replay will be accessible for 30 days following the event.

About Gritstone Oncology Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of cancer immunotherapies to fight multiple cancer types. Gritstone develops its products by leveraging two key pillars—first, a proprietary machine learning-based platform, Gritstone EDGE™, which is designed to predict, from a routine tumor biopsy, the tumor-specific neoantigens (TSNA) that are presented on a patient’s tumor cells; and second, the ability to develop and manufacture potent immunotherapies utilizing patients’ TSNA to potentially drive the patient’s immune system to specifically attack and destroy tumors. The company’s lead product candidate, GRANITE-001, is a personalized neoantigen-based immunotherapy beginning Phase 1 clinical testing. Gritstone’s second product candidate, SLATE-001, is a shared neoantigen (“off-the-shelf”) immunotherapy which is advancing towards the clinic. Novel tumor-specific antigens can also provide targets for bispecific antibody (BiSAb) therapeutics for solid tumors, and Gritstone’s BiSAb program is currently in lead optimization. For more information, please visit gritstoneoncology.com.

Contacts Media: Dan Budwick 1AB (973) 271-6085 dan@1abmedia.com

Investors: Alexandra Santos Wheelhouse Life Science Advisors (510) 871-6161 asantos@wheelhouselsa.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trading Platforms Poised for Billions by 2031

Updated Category News Views 3

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 2

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 2

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 2

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 1

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 2

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 2

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 7

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 3

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading

Top 5 Most Recently Viewed Articles

Stablecoins Surging: Key Players and Market Impacts Explored

Updated Category News Views 92

The Rise of Stablecoins in the Financial World Stablecoins are reshaping the global financial landscape, experiencing remarkable growth and increasing importance. Recently, their supply has reached an all-time high of $170 billion, and the monthly settlement volumes now exceed $1.4 trillion as of mid-2024. Key Insights from Analysts Experts have observed that stablecoins...

Continue Reading
CoRegen, Inc. Welcomes Dr. Sonal Gupta as CMO to Revolutionize Cancer Treatment

Updated Category News Views 232

CoRegen, Inc. Welcomes Dr. Sonal Gupta as Chief Medical Officer CoRegen, a progressive biopharmaceutical company known for tackling some of the toughest cancer types, proudly shares the appointment of Sonal Gupta, M.D., Ph.D., as its Chief Medical Officer (CMO). With a focus on revolutionizing treatment methods, Dr. Gupta's role will be pivotal in implementing advanced...

Continue Reading
Understanding Coupang's Recent Short Interest Trends

Updated Category News Views 86

Analyzing Recent Trends in Coupang's Short Interest Coupang (CPNG) has recently seen a notable reduction in its short interest. Specifically, the short percent of float has dropped by 11.11% since the last reporting period. Currently, there are 14.30 million shares sold short, which constitutes 1.44% of the total regular shares available for trading. Based on the...

Continue Reading
Saia Reports LTL Shipment Insights and Trends for Second Quarter

Updated Category News Views 177

Understanding Saia's LTL Shipment Performance Saia, Inc. (NASDAQ: SAIA), an established leader in the transportation sector, has released intriguing data regarding their less-than-truckload (LTL) services for the second quarter. The company's reports indicate a nuanced but telling shift in operations, highlighting how market dynamics are playing a role in their shipment...

Continue Reading
Insider Selling Trend: Randall K Fields Moves $159K in Stock

Updated Category News Views 428

Randall K Fields Takes Major Step with ReposiTrak Recently, Randall K Fields, the Chief Executive Officer at ReposiTrak (TRAK), revealed plans for his stock holdings by executing a significant insider sale. This transaction, categorized in the latest SEC filing, saw Fields selling 7,500 shares valued at approximately $159,360. As the stock market changes daily, ReposiTrak...

Continue Reading